Jun 15, 2005

Assessment of renal injury in vivo

Journal of Pharmacological and Toxicological Methods
Susan G Emeigh Hart

Abstract

The ICH S7A (Safety Pharmacology for Human Pharmaceuticals) guidelines specify that potential adverse pharmacologic effects of a test substance on renal function should be evaluated in supplemental studies when there is a cause for concern (ICH, 2001). For the most part, this can easily be accomplished by examination of the appropriate analytes in urine and blood collected as part of the routine preclinical safety studies. This review will serve as an overview of the selection, interpretation and limitations of standard clinical pathology methods (serum chemistry and urinalysis) for assessment of renal function in such studies, as well as provide some information on emerging biomarkers of renal function.

  • References102
  • Citations35

References

  • References102
  • Citations35

Mentioned in this Paper

Urinalysis
Metabolic Process, Cellular
Biochemical Pathway
Tryptophan
Urine
Dietary Intake
Kidney Function Tests
Creatinine
Human urine
Protein Degradation, Regulatory

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Justin WesthuyzenThomas J Morgan
Expert Opinion on Drug Metabolism & Toxicology
Vishal S Vaidya, Joseph V Bonventre
© 2020 Meta ULC. All rights reserved